Arteriosclerosis and Thrombosis, Vol 14, 453-459, Copyright © 1994 by American Heart Association

ARTICLES

Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release

E Thorin, CA Hamilton, MH Dominiczak and JL Reid
University of Glasgow, Department of Medicine and Therapeutics, Western Infirmary, UK.

We investigated the effect of chronic exposure (3 days) with low- density lipoprotein (LDL) and oxidized (Ox)-LDL on the unstimulated and stimulated formation of prostacyclin (6-keto-prostaglandin [PG]F1 alpha) and total inositol phosphates (IPs) by cultured bovine aortic endothelial cells. Neither basal nor bradykinin-stimulated (1 to 10 nmol/L) formation of 6-keto-PGF1 alpha was affected by LDL, except at the highest concentration of bradykinin tested (100 nmol/L). In the presence of the antioxidants N-acetyl-L-cysteine (NAC, 10 mumol/L) or vitamin E (100 mumol/L), basal and bradykinin-stimulated formation of 6- keto-PGF1 alpha was potentiated by 20 micrograms protein/mL of LDL. Ox- LDL decreased unstimulated formation of the eicosanoid from 3.1 +/- 0.2 pg/micrograms protein in control cells to 1.6 +/- 0.1 and 0.5 +/- 0.1 pg/microgram protein after 3-day incubation with 5 and 20 micrograms protein/mL of Ox-LDL, respectively (P < .05). As in the basal state, Ox- LDL decreased bradykinin-induced 6-keto-PGF1 alpha formation. NAC or vitamin E did not influence Ox-LDL-induced endothelial cell changes in eicosanoid production. IPs formation by endothelial cells increased to a similar extent in the presence of 20 micrograms protein/mL of either LDL or Ox-LDL. However, no change was apparent in the bradykinin (10 mumol/L)-induced increase in total IPs formation after incubation with the lipoproteins. The data indicate that chronic exposure to Ox-LDL abolishes the production of prostacyclin by cultured endothelial cells. The oxidatively modified lipoprotein seems to more specifically affect the prostacyclin pathway.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				F. L Ruberg and J. Loscalzo Prothrombotic determinants of coronary atherothrombosis Vascular Medicine, November 1, 2002; 7(4): 289 - 299. [Abstract] [PDF]

				A. MERTENS and P. HOLVOET Oxidized LDL and HDL: antagonists in atherothrombosis FASEB J, October 1, 2001; 15(12): 2073 - 2084. [Abstract] [Full Text] [PDF]

				M. G. Traber Does Vitamin E Decrease Heart Attack Risk? Summary and Implications with Respect to Dietary Recommendations J. Nutr., February 1, 2001; 131(2): 395S - 397. [Abstract] [Full Text]

				A. C. Chan Vitamin E and Atherosclerosis J. Nutr., October 1, 1998; 128(10): 1593 - 1596. [Abstract] [Full Text]

				S.-e. Chow, R.-s. Lee, S. H. Shih, and J.-k. Chen Oxidized LDL promotes vascular endothelial cell pinocytosis via a prooxidation mechanism FASEB J, July 1, 1998; 12(10): 823 - 830. [Abstract] [Full Text]

				M. Harada-Shiba, M. Kinoshita, H. Kamido, and K. Shimokado Oxidized Low Density Lipoprotein Induces Apoptosis in Cultured Human Umbilical Vein Endothelial Cells by Common and Unique Mechanisms J. Biol. Chem., April 17, 1998; 273(16): 9681 - 9687. [Abstract] [Full Text] [PDF]

				E. Thorin, M. A. Shatos, S. M. Shreeve, C. L. Walters, J. A. Bevan, and W. G. Mayhan Human Vascular Endothelium Heterogeneity: A Comparative Study of Cerebral and Peripheral Cultured Vascular Endothelial Cells Stroke, February 1, 1997; 28(2): 375 - 381. [Abstract] [Full Text]